COEP Fail-to-Deliver

Coeptis Therapeutics, Inc. (COEP) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $57.6M, listed on NASDAQ, employing roughly 5 people, carrying a beta of -0.43 to the broader market. Coeptis Therapeutics, Inc. Led by David Mehalick, public since 2020-12-17.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date

2026-04-27

Latest FTD Quantity

33.4K

Latest Price

$16.40

30-Day Avg FTD

3.8K

30-Day Total FTD

112.9K

Showing 30 days of SEC fail-to-deliver data for Coeptis Therapeutics, Inc..

Learn how fails-to-deliver is reported and how to read the data →